Sort
21,281 grants matching “influenza”
Mucosal M Cell Endocytosis: Specificity and Mechanisms
$225,000David D Lo · University Of California Riverside · R21 · FY2007 · AI
Influenza-pneumococcal synergism: role of neuraminidase
$225,000St. Jude Children'S Research Hospital · R21 · FY2003 · AI
Influenza-pneumococcal synergism: role of neuraminidase
$225,000St. Jude Children'S Research Hospital · R21 · FY2004 · AI
A Web Service for Fragment-based Selectivity Analysis of Drug Leads
$225,000John Laurence Kulp III · Conifer Point Pharmaceuticals, Llc · R43 · FY2020 · GM
Role of Cellular P-bodies and Hantavirus Nucleocapsid Protein in Viral mRNA "cap
$225,000Mohammad A Mir · University Of Kansas Medical Center · R21 · FY2009 · AI
Lateral Flow-Electrochemiluminescent (LF-ECL) Test Strips and Portable Reader for Ultrasensitive Foodborne Pathogen Detection
$225,000John Bruno · Nanohmics, Inc. · R43 · FY2022 · CK
Role of TRAIL in immunity to influenza virus infections
$225,000Kevin L Legge · University Of Iowa · R21 · FY2007 · AI
Detecting species-specific bacterial meningitis markers with iDDS probes
$225,000David A Shafer · Genetag Technology, Inc. · R43 · FY2018 · IP
The Role of Oxidative Epithelial Defenses in Influenza Infection
$225,000Balazs Rada · University Of Georgia · R21 · FY2018 · AI
STRENGTHENING INFLUENZA SURVEILLANCE AND PANDEMIC PREPAREDNESS
$225,000Nurbolot Usenbaev · Ministry Of Health / Kyrgyz Republic · U51 · FY2015 · IP
Expanding the Use of Seasonal Influenza Vaccines in Public Health Programs in Chi
$225,000Hongjie Yu · Chinese Ctr-Disease Control/Prevention · U51 · FY2015 · IP
Preclinical Studies of PG70 LEAPS Peptide Vaccines for Rheumatoid Arthritis
$224,999Daniel Hill Zimmerman · Cel-Sci Corporation · R43 · FY2014 · AR
A Single Antiviral to Treat Multiple Opportunistic Infections
$224,999Emre Koyuncu · Evrys Bio, Llc · R43 · FY2014 · AI
Restimulating memory T cell responses in elderly by a novel, live influenza vaccine
$224,997Pamuk Bilsel · Flugen, Inc. · R41 · FY2015 · AI
Stabilization of Influenza Vaccine by Silica-Coating
$224,993James R Laidler · Stonestable, Inc. · R41 · FY2016 · AI
Engineering Nanoparticle Alum Adjuvants for Pandemic Influenza Vaccines
$224,984Mark Orr · Hdt Bio Corporation · R43 · FY2018 · IP
A NUTRITIVE VACCINE ADJUVANT AGAINST INFLUENZA
$224,981Michael Vajdy · Epitogenesis, Inc. · N43 · FY2014 · AI
Adenoviral-based vaccine platform to overcome neutralizing immunity
$224,978Andrea Gambotto · University Of Pittsburgh At Pittsburgh · R21 · FY2011 · AI
Sample Preparation and Screening of Non-invasive Pediatric Specimens for Lower Respiratory Disease
$224,978Rebecca Holmberg · Akonni Biosystems, Inc. · N43 · FY2017 · AI
Multivalent influenza vaccine using recombinant outer membrane vesicles
$224,974Christopher Locher · Versatope Therapeutics, Inc. · R43 · FY2019 · AI
Synthetic Universal Flu Vaccine
$224,966Christopher H Clegg · Tria Bioscience Corporation · R43 · FY2018 · IP
Development of RespiraClear for targeted mucosal treatment of RSV infections
$224,961Richard A Cone · Mucommune, Llc · R44 · FY2019 · AI
Improved RSV F Vaccine Candidates
$224,956Gregory John Tobin · Biological Mimetics, Inc. · R43 · FY2018 · AI
A Laparoscopic Grasping Instrument for Robust and Atraumatic Tissue Manipulation in Minimally-Invasive Gastrointestinal Surgery
$224,952Michael Jaasma · Theranova, Llc · R43 · FY2020 · AG
Therapeutic Antibodies for Biofilm Infections
$224,946Lawrence Michael Kauvar · Trellis Bioscience, Inc. · R41 · FY2015 · AI